These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 7700641)

  • 1. MAP kinase activation is essential for oncogenic transformation of NIH3T3 cells by Mos.
    Okazaki K; Sagata N
    Oncogene; 1995 Mar; 10(6):1149-57. PubMed ID: 7700641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effects of insulin on the activation of the Raf/Mos-dependent MAP kinase cascade in vitellogenic versus postvitellogenic Xenopus oocytes.
    Chesnel F; Bonnec G; Tardivel A; Boujard D
    Dev Biol; 1997 Aug; 188(1):122-33. PubMed ID: 9245517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mos activates MAP kinase in mouse oocytes through two opposite pathways.
    Verlhac MH; Lefebvre C; Kubiak JZ; Umbhauer M; Rassinier P; Colledge W; Maro B
    EMBO J; 2000 Nov; 19(22):6065-74. PubMed ID: 11080153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutagenic analysis of functional domains of the mos proto-oncogene and identification of the sites important for MAPK activation and DNA binding.
    Fukasawa K; Zhou R; Matten WT; Armstrong AJ; Daar I; Oskarsson M; Sathyanarayana BK; Maclvor L; Wood TG; Vande Woude GF
    Oncogene; 1995 Oct; 11(8):1447-57. PubMed ID: 7478569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the Xenopus oocyte mitogen-activated protein kinase pathway by Mos is independent of Raf.
    Shibuya EK; Morris J; Rapp UR; Ruderman JV
    Cell Growth Differ; 1996 Feb; 7(2):235-41. PubMed ID: 8822207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cot protooncoprotein activates the dual specificity kinases MEK-1 and SEK-1 and induces differentiation of PC12 cells.
    Hagemann D; Troppmair J; Rapp UR
    Oncogene; 1999 Feb; 18(7):1391-400. PubMed ID: 10050876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of MEK1 phosphorylation by the v-Mos protein.
    Pham CD; Arlinghaus RB; Zheng CF; Guan KL; Singh B
    Oncogene; 1995 Apr; 10(8):1683-8. PubMed ID: 7731726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergy between the Mos/mitogen-activated protein kinase pathway and loss of p53 function in transformation and chromosome instability.
    Fukasawa K; Vande Woude GF
    Mol Cell Biol; 1997 Jan; 17(1):506-18. PubMed ID: 8972231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential contribution of the ERK and JNK mitogen-activated protein kinase cascades to Ras transformation of HT1080 fibrosarcoma and DLD-1 colon carcinoma cells.
    Plattner R; Gupta S; Khosravi-Far R; Sato KY; Perucho M; Der CJ; Stanbridge EJ
    Oncogene; 1999 Mar; 18(10):1807-17. PubMed ID: 10086335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mek1 phosphorylation site mutants activate Raf-1 in NIH 3T3 cells.
    Alessandrini A; Greulich H; Huang W; Erikson RL
    J Biol Chem; 1996 Dec; 271(49):31612-8. PubMed ID: 8940180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RAS signalling is abnormal in a c-raf1 MEK1 double mutant.
    Bottorff D; Stang S; Agellon S; Stone JC
    Mol Cell Biol; 1995 Sep; 15(9):5113-22. PubMed ID: 7651428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The chimeric protein tyrosine kinase ETV6-NTRK3 requires both Ras-Erk1/2 and PI3-kinase-Akt signaling for fibroblast transformation.
    Tognon C; Garnett M; Kenward E; Kay R; Morrison K; Sorensen PH
    Cancer Res; 2001 Dec; 61(24):8909-16. PubMed ID: 11751416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Requirement for Raf and MAP kinase function during the meiotic maturation of Xenopus oocytes.
    Fabian JR; Morrison DK; Daar IO
    J Cell Biol; 1993 Aug; 122(3):645-52. PubMed ID: 8335690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conditionally oncogenic forms of the A-Raf and B-Raf protein kinases display different biological and biochemical properties in NIH 3T3 cells.
    Pritchard CA; Samuels ML; Bosch E; McMahon M
    Mol Cell Biol; 1995 Nov; 15(11):6430-42. PubMed ID: 7565795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MEK1 mediates a positive feedback on Raf-1 activity independently of Ras and Src.
    Zimmermann S; Rommel C; Ziogas A; Lovric J; Moelling K; Radziwill G
    Oncogene; 1997 Sep; 15(13):1503-11. PubMed ID: 9380402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
    Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
    Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple pathways for activation of MAP kinases.
    Mitra G; Weber M; Stacey D
    Cell Mol Biol Res; 1993; 39(5):517-23. PubMed ID: 8173594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitogen-activated protein kinase/extracellular signal-regulated protein kinase activation by oncogenes, serum, and 12-O-tetradecanoylphorbol-13-acetate requires Raf and is necessary for transformation.
    Troppmair J; Bruder JT; Munoz H; Lloyd PA; Kyriakis J; Banerjee P; Avruch J; Rapp UR
    J Biol Chem; 1994 Mar; 269(9):7030-5. PubMed ID: 8120067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation.
    Khosravi-Far R; White MA; Westwick JK; Solski PA; Chrzanowska-Wodnicka M; Van Aelst L; Wigler MH; Der CJ
    Mol Cell Biol; 1996 Jul; 16(7):3923-33. PubMed ID: 8668210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transformation of mammalian cells by constitutively active MAP kinase kinase.
    Mansour SJ; Matten WT; Hermann AS; Candia JM; Rong S; Fukasawa K; Vande Woude GF; Ahn NG
    Science; 1994 Aug; 265(5174):966-70. PubMed ID: 8052857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.